Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumors
Titel:
Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumors
Auteur:
Do, Khanh T. O’Sullivan Coyne, Geraldine Hays, John L. Supko, Jeffrey G. Liu, Stephen V. Beebe, Kristin Neckers, Len Trepel, Jane B. Lee, Min-Jung Smyth, Tomoko Gannon, Courtney Hedglin, Jennifer Muzikansky, Alona Campos, Susana Lyons, John Ivy, Percy Doroshow, James H. Chen, Alice P. Shapiro, Geoffrey I.